Search Results
Aug 12, 2026, 21:00 ET ArkBio Announces China IND Approval for its Antiviral Drug-Fc Conjugate (AFC) Candidate AK0406 for Influenza Prophylaxis
ArkBioArkBio is a commercial-stage biotechnology company focused on the discovery and development of innovative therapeutics for respiratory/lung and pediatric diseases. Founded in 2014, the company has established proprietary technology platforms and a differentiated R&D pipeline through
More news about: Shanghai Ark Biopharmaceutical Co., Ltd.
Aug 12, 2026, 21:00 ET ArkBio Announces China IND Approval for its Antiviral Drug-Fc Conjugate (AFC) Candidate AK0406 for Influenza Prophylaxis
ArkBioArkBio is a commercial-stage biotechnology company focused on the discovery and development of innovative therapeutics for respiratory/lung and pediatric diseases. Founded in 2014, the company has established proprietary technology platforms and a differentiated R&D pipeline through
More news about: Shanghai Ark Biopharmaceutical Co., Ltd.
Aug 12, 2026, 10:01 ET Cancer Tumor Profiling Market worth $19.87 billion by 2031 - Exclusive Report by MarketsandMarkets™
tumors and liquid tumors or hematologic malignancies. In 2025, solid tumors accounted for the largest share, driven by high testing volumes across lung, breast, colorectal, prostate, gynecologic, melanoma, brain and central nervous system, head and neck, gastrointestinal, pancreatic, liver, and biliary
More news about: MarketsandMarkets
Aug 12, 2026, 08:30 ET IceCure Reports its Financial Results for the First Half of 2026 with 45% Revenue Growth Year-Over-Year
cryoablation therapy systems for the destruction of tumors (benign and cancerous) by freezing, with the primary focus areas being breast, kidney, bone and lung cancer. Its minimally invasive technology is a safe and effective option to surgical tumor removal that is easily performed in a relatively short procedure.
More news about: IceCure Medical
Aug 12, 2026, 08:17 ET Ivonescimab Plus Chemotherapy Approved for First-Line Squamous NSCLC; HARMONi-6 Establishes New Gold Standard in Lung Cancer Treatment
chemotherapy for the first-line treatment of advanced squamous non-small cell lung cancer (sq-NSCLC). The approval of ivonescimab combination therapy as a first-line treatment for squamous NSCLC marks the third lung cancer indication for ivonescimab. In a randomized, double-blind Phase III trial,
More news about: Akeso, Inc.
Aug 12, 2026, 06:05 ET RyboDyn Unveils a Hidden Human Proteome and a New Universe of Actionable Cancer Targets
druggable targets per indication across both routes.RyboDyn's top-ranked cell-surface candidate is upregulated roughly 7.5-fold in ~80% of the lung squamous cell carcinoma patients assessed (a cohort of over 100), with significant tumor upregulation also seen in clear cell renal cell carcinoma (ccRCC)
More news about: RyboDyn
Aug 11, 2026, 20:22 ET Galvanize Therapeutics® Announces First Commercial Procedures Using the New Aliya® EX System
Galvanize Therapeutics, Inc., a commercial-stage medical technology company pioneering pulsed electric field (PEF) therapies for oncology and chronic lung disease, today announced the completion of the first commercial procedures using its recently FDA-cleared Aliya EX System.
More news about: Galvanize Therapeutics, Inc.
Aug 11, 2026, 14:45 ET From Asthma to Tobacco, American Lung Association Helps Schools Create Healthier Learning Environments
here.About the American Lung Association The American Lung Association is the leading organization working to save lives by improving lung health and preventing lung disease through education, advocacy and research. The work of the American Lung Association is focused on four strategic
More news about: American Lung Association
Aug 11, 2026, 13:37 ET St. Luke's Announces New Heart Hospital
best treat our cardiac patients. This includes brand new, state-of-the-art imaging equipment to see and assess the most intricate heart issues, heart-lung machines to take over pumping blood during open-heart surgeries and extracorporeal membrane oxygenation (ECMO) machines to provide patients with continuous,
More news about: St. Luke’s University Health Network, Inc.
Aug 11, 2026, 09:56 ET Bitmine Immersion Technologies (BMNR) Công Bố Lượng ETH Nắm Giữ Đạt 5,81 Triệu Token, Đưa Tổng Tài Sản Tiền Mã Hóa và Tiền Mặt Lên Mức 11,6 Tỷ USD
liên kết tại đây) cho tháng 7 năm 2026. Tiêu đề của Thông Điệp này là "ETH chính là liều thuốc giải cho Thung Lũng Kỳ Lạ của Sự Giàu Có."Vào đầu năm 2026, Bitmine đã ra mắt MAVAN (Made in American VAlidator Network) — nền tảng staking chuyên biệt dành cho
More news about: Bitmine Immersion Technologies, Inc.
Aug 11, 2026, 08:54 ET South Florida Donor Network Honors 80-Year-Old Miami Woman as Oldest Known DCD Lung Donor in Transplant History
through the decision to say yes to donation. Her lifesaving gift provided a second chance at life for a 65-year-old woman who received a successful lung transplant in Florida."Over 55 years ago, upon my first encounter with 'My Mary,' I felt like God had sent me my forever mate. Mary didn't feel
More news about: South Florida Donor Network
Aug 11, 2026, 08:00 ET Synchrony Medical Enrolling Bronchiectasis Patients in Real-World Study to Evaluate Impact of LibAirty™ Airway Clearance System
12-month medical history. Bronchiectasis is a chronic lung condition in which damaged, widened airways lead to mucus accumulation in the lungs, driving a cycle of persistent cough, recurrent infections, and long-term decline in lung function. For the hundreds of thousands of Americans living with
More news about: Synchrony Medical
Aug 11, 2026, 08:00 ET Sentynl Therapeutics and Mereo BioPharma Announce Option and License Agreement for alvelestat in Alpha-1 Antitrypsin Deficiency-Associated Lung Disease (AATD-LD)
neutrophil elastase (NE), a key enzyme involved in inflammation and the destruction of lung tissue. As a small molecule, alvelestat is able to access both cell-bound and soluble elastase and effectively penetrate lung tissue. The safety and tolerability profile of alvelestat has been established through
More news about: Sentynl Therapeutics
Aug 10, 2026, 10:01 ET Ventilators Market worth $3.10 billion by 2031 - Exclusive Report by MarketsandMarkets™
responding with broader universal platforms, neonatal options, compact transport systems, remote software updates, interoperable data exchange, and automated lung-protective or weaning functions. Hospitals are increasingly evaluating vendors on installed-base support, cybersecurity, service continuity, consumable
More news about: MarketsandMarkets
Aug 10, 2026, 09:24 ET Florida Cancer Specialists & Research Institute Welcomes Neel K. Gakhar, MD
Gakhar provides comprehensive care for patients with cancer and blood disorders, with a primary clinical interest in thoracic oncology, particularly lung cancer. He is also interested in the expanding roles of immunotherapy, targeted therapy and molecular testing across cancer types, and how these advances
More news about: Florida Cancer Specialists & Research Institute
Aug 10, 2026, 07:38 ET Brayton Purcell LLP Releases The Best of From Dust to Verdict: Season 1, Part 1
conditions associated with respirable crystalline silica exposure, including lung cancer, chronic obstructive pulmonary disease (COPD), chronic kidney disease, autoimmune diseases, sarcoidosis, tuberculosis, and other lung infections. The episode also addresses the potential for misdiagnosis, including
More news about: Brayton Purcell LLP
Aug 10, 2026, 02:36 ET Sobi enters strategic partnership with Innate Pharma to license lacutamab in T-cell lymphoma
antibody developed in cutaneous T cell lymphomas and monalizumab, an anti-NKG2A antibody developed in collaboration with AstraZeneca in non-small cell lung cancer (NSCLC).Sobi®Sobi is a global biopharma company unlocking the potential of breakthrough innovations, transforming everyday
More news about: Swedish Orphan Biovitrum AB
Aug 10, 2026, 02:32 ET Sobi enters strategic partnership with Innate Pharma to license lacutamab in T-cell lymphoma
antibody developed in cutaneous T cell lymphomas and monalizumab, an anti-NKG2A antibody developed in collaboration with AstraZeneca in non-small cell lung cancer (NSCLC).Sobi®Sobi is a global biopharma company unlocking the potential of breakthrough innovations, transforming everyday
More news about: Swedish Orphan Biovitrum AB
Aug 10, 2026, 00:05 ET Akeso Advances IO2.0 + ADC2.0 Strategy: First Patient Dosed in Phase II Study of TROP2/Nectin-4 Bispecific ADC (AK146D1) Combined with Ivonescimab in Breast Cancer
cancer.Guided by its IO2.0 + ADC2.0 strategy, Akeso is driving the continuous evolution of treatment paradigms for major malignancies such as non-small cell lung cancer and breast cancer.In the immuno-oncology field, Akeso has two approved bispecific antibodies for cancer treatment. The Company is actively
More news about: Akeso, Inc.
Aug 09, 2026, 22:26 ET HanchorBio and Taiwan Cancer Moonshot Project-NTU Subteam Led by Professor Sung-Liang Yu Establish Strategic Collaboration to Advance Precision Oncology
across different populations, including landmark studies of major cancers in Taiwan, lung adenocarcinoma published in Cell 2020, a cross-population analysis of lung adenocarcinoma across Asian, North American, and Eastern European cohorts, published in Cancer Cell
More news about: HanchorBio Inc.
Aug 07, 2026, 07:30 ET Alpha Announces Financial Results for Second Quarter 2026
9,841Workers' compensation and black lung obligations188,596
More news about: ALPHA METALLURGICAL RESOURCES, INC.
Aug 07, 2026, 05:09 ET FAMILIARITÉ: Sự giao thoa đầy chất thơ giữa điện ảnh và văn học
chuyện trên mặt nước. Một trong những cuộc trao đổi thân mật nhất của video diễn ra giữa Isabelle và bạn diễn trên một chiếc thuyền chèo nhỏ trôi lững thững trên ao của khu vườn. Việc đưa một camera điện ảnh truyền thống cùng ê-kíp vào một không gian chật hẹp và chòng chành như vậy gần như là bất
More news about: DJI
Aug 06, 2026, 16:25 ET CytoSorbents Reports Second Quarter 2026 Financial Results, Recent Business Highlights, and Regulatory Update
blood pumps already in the hospital (e.g. dialysis, continuous renal replacement therapy or CRRT, extracorporeal membrane oxygenation or ECMO, and heart-lung machines), where blood is repeatedly recirculated outside the body, through our cartridges where toxic substances are removed, and then back into the
More news about: Cytosorbents Corp
Aug 06, 2026, 09:03 ET MedStar Georgetown Surgeons Make History with Three Single-Port Robotic Surgery Firsts in One Week
a patient's lung through a single incision. Traditional minimally invasive lung procedures require incisions between the ribs. Instead, Dr. Margolis made a single incision below the rib cage. This approach may reduce pain while still providing surgeons with excellent access to the lung."The ability
More news about: MedStar Health
Aug 06, 2026, 08:43 ET Pusan National University Introduces ASTRA-Net for Improved Lung Airway Mapping
bronchoscopy proceduresBUSAN, South Korea, Aug. 6, 2026 /PRNewswire/ -- Lung cancer is the most diagnosed cancer globally and is one of the leading causes of cancer-related deaths. Early detection can improve survival. However,
More news about: Pusan National University